That is why I agree with many posters that a serious BP looking to take us out should understand the implications of the PM results, how the drug works and would be looking to act sooner rather than later.
What is very unclear for me is what the NEU board would deem acceptable at this stage and what they are willing to leave on the table so to speak by not completing all ph2 trials. Then there’s also the impetus to get the drug to market in the shortest time possible for sufferers.
Potential Takeover, page-23
-
- There are more pages in this discussion • 99 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.00 |
Change
0.090(0.45%) |
Mkt cap ! $2.556B | |||
| Open | High | Low | Value | Volume |
| $19.88 | $20.07 | $19.73 | $11.80M | 591.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 5901 | $19.97 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.00 | 3262 | 5 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| NEU (ASX) Chart |